Investing
Merck in late-stage talks to acquire Prometheus Biosciences -WSJ
© Reuters. FILE PHOTO: Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, U.S., November 13, 2021. REUTERS/Andrew Kelly
(Reuters) – Merck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter.
Read the full article here
-
Side Hustles5 days ago
5 Things That Could Significantly Impact Your Company in 2025
-
Investing5 days ago
NFI Group surge after board reshaped with new appointments, chairperson By Investing.com
-
Side Hustles6 days ago
How Failing 22 Times Paved the Way to My Success
-
Passive Income4 days ago
3 Challenges Entrepreneurs Will Face in 2025
-
Side Hustles6 days ago
3 Strategies to Make Your Next Campaign Go Viral
-
Make Money2 days ago
10 Critical Questions to Ask Your Financial Advisor Now
-
Side Hustles4 days ago
The Canadian Media Lawsuit That Could Reshape Tech’s Future
-
Investing6 days ago
Chinese hack of US telecoms compromised more firms than previously known, WSJ says By Reuters